Megan Robertson, Member of the Firm, presents “The Next-Gen Regulatory Arena” at the Food & Drug Law Institute (FDLI) Digital Health Technology and Regulation Conference, which runs from February 26 to 27.
This session anticipates what digital health stakeholders should expect from the new administration in a Loper Bright world. As more states enact laws over emerging technology, agencies produce guidance on use, and appointees are announced, questions about telemedicine licensing, data privacy, Medicaid reimbursement, and health equity emerge. Panelists explore these topics through the lens of regulatory authority, interpretation, and preemption.
For more information, please visit FDLI.org.
Event Detail
Virtual Event